YS Biopharma Co., Ltd. Ordinary Shares
Compare this stock
YS Stock Report Card
$
15%
Performance
Score:
10/100
YS returned -94.73% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Volatility
Score:
23/100
YS has had a lower than average amount of volatility over the last 12 months giving it a score of 22 of 100.
YS Biopharma Co., Ltd. Ordinary Shares Summary
Nasdaq / YS
Healthcare
Biotechnology
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
YS scored poorly on our reportcard. Here are some similar companies and how they performed.
